Plain-English translation of NCT05626348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Arthritis, Rheumatoid research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether different drug combinations—including , , Adalimumab, , and —can help people with rheumatoid arthritis feel better and stop disease progression. Researchers will also look at blood and joint fluid samples to understand which patients respond best to each medication combination. The study lasts 24 weeks (about 6 months).
Rheumatoid arthritis is a condition where the immune system attacks the joints, causing pain and damage. Doctors want to find the best combination of medications to help patients reach remission (where symptoms disappear or improve greatly), and to predict which patients will respond to specific treatments.
You likely qualify if…
You likely don't qualify if…
You will be assigned to take one of three medication combinations by mouth and/or injection, with doses adjusted based on how you respond. You'll visit the hospital regularly over 24 weeks so doctors can check your symptoms, measure inflammation in your blood, and potentially collect samples from your joints. The goal is to see how well the medication works and to understand what makes some people respond better than others.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
China